Kevin Phelan
Concepts (258)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurons | 19 | 2019 | 486 | 2.190 |
Why?
| TRPC Cation Channels | 5 | 2020 | 19 | 2.100 |
Why?
| Seizures | 4 | 2015 | 208 | 1.640 |
Why?
| Status Epilepticus | 4 | 2020 | 37 | 1.370 |
Why?
| Cadaver | 3 | 2021 | 113 | 0.870 |
Why?
| Embalming | 2 | 2021 | 9 | 0.860 |
Why?
| Manikins | 2 | 2021 | 40 | 0.800 |
Why?
| Urinary Catheters | 1 | 2021 | 6 | 0.780 |
Why?
| Pro-Opiomelanocortin | 2 | 2019 | 10 | 0.740 |
Why?
| Melanocortins | 1 | 2019 | 3 | 0.700 |
Why?
| Brain | 8 | 2020 | 1387 | 0.690 |
Why?
| Appetite | 1 | 2019 | 19 | 0.690 |
Why?
| Radiology, Interventional | 1 | 2018 | 35 | 0.640 |
Why?
| Ultrasonography, Interventional | 2 | 2018 | 146 | 0.640 |
Why?
| Theta Rhythm | 2 | 2016 | 12 | 0.620 |
Why?
| Pilocarpine | 5 | 2020 | 23 | 0.570 |
Why?
| Spinal Cord | 5 | 2000 | 151 | 0.560 |
Why?
| Animals | 43 | 2021 | 14385 | 0.560 |
Why?
| Synaptic Transmission | 6 | 1999 | 95 | 0.550 |
Why?
| Behavior, Animal | 1 | 2015 | 200 | 0.480 |
Why?
| Cerebellum | 5 | 2021 | 142 | 0.460 |
Why?
| Mice | 12 | 2021 | 6413 | 0.450 |
Why?
| CA1 Region, Hippocampal | 1 | 2012 | 28 | 0.440 |
Why?
| Mice, Knockout | 5 | 2020 | 926 | 0.430 |
Why?
| Transforming Growth Factor beta | 3 | 1997 | 158 | 0.410 |
Why?
| Signal Transduction | 1 | 2019 | 1753 | 0.410 |
Why?
| Electroencephalography | 4 | 2020 | 356 | 0.380 |
Why?
| Microglia | 3 | 2021 | 137 | 0.380 |
Why?
| Ethanol | 4 | 2015 | 322 | 0.380 |
Why?
| Rats | 26 | 2005 | 3415 | 0.380 |
Why?
| Paraventricular Hypothalamic Nucleus | 2 | 2019 | 9 | 0.350 |
Why?
| Receptors, GABA-B | 2 | 1999 | 12 | 0.340 |
Why?
| Electrophysiology | 7 | 2005 | 76 | 0.340 |
Why?
| Disease Models, Animal | 5 | 2020 | 1639 | 0.320 |
Why?
| Mice, Inbred C57BL | 7 | 2021 | 1999 | 0.280 |
Why?
| Hydroxycholesterols | 4 | 1998 | 9 | 0.280 |
Why?
| Trigeminal Nucleus, Spinal | 3 | 1991 | 3 | 0.270 |
Why?
| Medulla Oblongata | 3 | 1989 | 12 | 0.260 |
Why?
| Synapses | 3 | 1997 | 90 | 0.260 |
Why?
| Rats, Sprague-Dawley | 9 | 2000 | 1663 | 0.240 |
Why?
| Receptors, Metabotropic Glutamate | 2 | 2014 | 14 | 0.240 |
Why?
| Long-Term Potentiation | 2 | 2014 | 26 | 0.240 |
Why?
| Corpus Striatum | 2 | 1999 | 66 | 0.230 |
Why?
| Clinical Clerkship | 1 | 2023 | 36 | 0.230 |
Why?
| Immunity | 2 | 2013 | 36 | 0.230 |
Why?
| Septal Nuclei | 3 | 1993 | 4 | 0.230 |
Why?
| Central Nervous System Depressants | 2 | 2013 | 78 | 0.220 |
Why?
| Animals, Newborn | 3 | 2000 | 396 | 0.220 |
Why?
| Engineering | 1 | 2022 | 7 | 0.220 |
Why?
| Technology | 1 | 2022 | 18 | 0.220 |
Why?
| Trigeminal Nuclei | 3 | 1991 | 4 | 0.210 |
Why?
| Cerebral Cortex | 4 | 2015 | 234 | 0.200 |
Why?
| Minority Groups | 1 | 2022 | 136 | 0.200 |
Why?
| Superior Cervical Ganglion | 2 | 1998 | 7 | 0.200 |
Why?
| Students, Medical | 1 | 2023 | 173 | 0.200 |
Why?
| Galanin | 1 | 2000 | 2 | 0.190 |
Why?
| Aging | 4 | 2013 | 784 | 0.190 |
Why?
| Nursing Education Research | 1 | 2021 | 42 | 0.190 |
Why?
| Astrocytes | 2 | 2013 | 142 | 0.190 |
Why?
| Students | 1 | 2022 | 207 | 0.190 |
Why?
| S100 Proteins | 1 | 2000 | 41 | 0.180 |
Why?
| Autoreceptors | 1 | 1999 | 1 | 0.180 |
Why?
| Sulfhydryl Reagents | 1 | 1999 | 3 | 0.180 |
Why?
| Ethylmaleimide | 1 | 1999 | 4 | 0.180 |
Why?
| N-Methylaspartate | 3 | 1996 | 27 | 0.180 |
Why?
| Excitatory Postsynaptic Potentials | 1 | 1999 | 36 | 0.180 |
Why?
| Temporal Lobe | 1 | 2000 | 74 | 0.180 |
Why?
| Lysine | 1 | 2000 | 102 | 0.180 |
Why?
| Electric Stimulation | 4 | 2014 | 95 | 0.170 |
Why?
| Peptide Fragments | 1 | 2000 | 242 | 0.170 |
Why?
| alpha-MSH | 1 | 2019 | 18 | 0.170 |
Why?
| Anti-Obesity Agents | 1 | 2019 | 22 | 0.170 |
Why?
| Receptor, Melanocortin, Type 4 | 1 | 2019 | 17 | 0.170 |
Why?
| Muscle, Smooth, Vascular | 1 | 2020 | 140 | 0.170 |
Why?
| Clinical Competence | 2 | 2023 | 446 | 0.170 |
Why?
| Ganglia, Spinal | 2 | 1989 | 50 | 0.170 |
Why?
| Sex Characteristics | 1 | 2000 | 214 | 0.170 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 44 | 0.170 |
Why?
| Ion Channel Gating | 2 | 1997 | 47 | 0.160 |
Why?
| Analysis of Variance | 3 | 2016 | 635 | 0.160 |
Why?
| Action Potentials | 5 | 2014 | 131 | 0.160 |
Why?
| Rats, Inbred Strains | 9 | 1992 | 172 | 0.160 |
Why?
| Nephrology | 1 | 2018 | 17 | 0.160 |
Why?
| Vestibular Nuclei | 3 | 1992 | 6 | 0.160 |
Why?
| Phantoms, Imaging | 1 | 2018 | 126 | 0.160 |
Why?
| Immunity, Cellular | 2 | 2015 | 80 | 0.160 |
Why?
| Receptors, GABA-A | 1 | 1997 | 15 | 0.160 |
Why?
| Potassium Channels | 1 | 1997 | 41 | 0.150 |
Why?
| Male | 19 | 2020 | 27334 | 0.150 |
Why?
| Peptides | 1 | 2019 | 276 | 0.150 |
Why?
| Real-Time Polymerase Chain Reaction | 3 | 2013 | 206 | 0.150 |
Why?
| Repressor Proteins | 1 | 2019 | 165 | 0.150 |
Why?
| Muscarinic Agonists | 1 | 2016 | 12 | 0.150 |
Why?
| Humans | 8 | 2023 | 54284 | 0.150 |
Why?
| Thiazolidinediones | 2 | 2015 | 95 | 0.150 |
Why?
| Diet, High-Fat | 1 | 2019 | 216 | 0.150 |
Why?
| Cell Death | 3 | 2012 | 223 | 0.150 |
Why?
| Spectrum Analysis | 1 | 2016 | 79 | 0.140 |
Why?
| Immunohistochemistry | 3 | 2013 | 1089 | 0.140 |
Why?
| Excitatory Amino Acids | 1 | 1996 | 1 | 0.140 |
Why?
| Cells, Cultured | 6 | 2011 | 1737 | 0.140 |
Why?
| Excitatory Amino Acid Agonists | 1 | 1996 | 23 | 0.140 |
Why?
| Receptors, N-Methyl-D-Aspartate | 2 | 1996 | 121 | 0.140 |
Why?
| Reaction Time | 1 | 2016 | 227 | 0.140 |
Why?
| CA3 Region, Hippocampal | 1 | 2014 | 5 | 0.130 |
Why?
| Pyramidal Cells | 1 | 2014 | 20 | 0.120 |
Why?
| Microscopy, Electron | 2 | 2011 | 97 | 0.120 |
Why?
| Models, Neurological | 1 | 2014 | 62 | 0.120 |
Why?
| Obesity | 2 | 2019 | 1202 | 0.110 |
Why?
| Spatial Behavior | 1 | 2012 | 13 | 0.110 |
Why?
| Mice, 129 Strain | 1 | 2012 | 49 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 1 | 2016 | 1476 | 0.110 |
Why?
| Neuroimmunomodulation | 1 | 2012 | 14 | 0.110 |
Why?
| Microelectrodes | 4 | 2000 | 21 | 0.110 |
Why?
| Kidney | 1 | 2018 | 820 | 0.110 |
Why?
| Receptors, Muscarinic | 1 | 1992 | 18 | 0.110 |
Why?
| Neurons, Afferent | 2 | 1989 | 35 | 0.110 |
Why?
| Receptors, Nicotinic | 1 | 1992 | 80 | 0.100 |
Why?
| Hippocampus | 4 | 2015 | 242 | 0.100 |
Why?
| Thalamus | 1 | 1991 | 33 | 0.100 |
Why?
| Nerve Growth Factors | 3 | 2000 | 32 | 0.100 |
Why?
| Time Factors | 2 | 2016 | 3213 | 0.090 |
Why?
| PPAR gamma | 1 | 2011 | 79 | 0.090 |
Why?
| Receptors, Histamine | 1 | 1990 | 7 | 0.090 |
Why?
| Vestibular Nerve | 1 | 1990 | 5 | 0.090 |
Why?
| Horseradish Peroxidase | 4 | 1991 | 23 | 0.090 |
Why?
| Histamine | 1 | 1990 | 28 | 0.090 |
Why?
| Patch-Clamp Techniques | 5 | 2005 | 148 | 0.090 |
Why?
| Lumbar Vertebrae | 2 | 2000 | 105 | 0.090 |
Why?
| Membrane Potentials | 6 | 2000 | 139 | 0.090 |
Why?
| Neural Pathways | 3 | 1996 | 97 | 0.080 |
Why?
| beta-Cyclodextrins | 2 | 1998 | 18 | 0.080 |
Why?
| PC12 Cells | 2 | 1998 | 31 | 0.080 |
Why?
| Pregnancy | 4 | 2021 | 2620 | 0.080 |
Why?
| Glial Fibrillary Acidic Protein | 2 | 2013 | 37 | 0.080 |
Why?
| Motor Neurons | 2 | 1997 | 31 | 0.080 |
Why?
| Serotonin | 2 | 1997 | 159 | 0.070 |
Why?
| Receptors, Peptide | 1 | 2005 | 10 | 0.070 |
Why?
| Thalamic Nuclei | 1 | 2005 | 10 | 0.070 |
Why?
| Axons | 4 | 1992 | 43 | 0.060 |
Why?
| Sodium | 3 | 2000 | 102 | 0.060 |
Why?
| Sutures | 1 | 2023 | 45 | 0.060 |
Why?
| DNA, Complementary | 2 | 2013 | 145 | 0.060 |
Why?
| Chemokine CCL2 | 2 | 2013 | 78 | 0.060 |
Why?
| Dendrites | 3 | 1993 | 28 | 0.060 |
Why?
| Globus Pallidus | 1 | 1982 | 6 | 0.060 |
Why?
| Gene Expression | 2 | 2021 | 664 | 0.050 |
Why?
| Female | 7 | 2021 | 28441 | 0.050 |
Why?
| RNA | 2 | 2013 | 202 | 0.050 |
Why?
| Cell Survival | 2 | 2011 | 657 | 0.050 |
Why?
| Chemokine CX3CL1 | 1 | 2021 | 9 | 0.050 |
Why?
| Receptors, Serotonin | 2 | 1997 | 22 | 0.050 |
Why?
| Chick Embryo | 2 | 1997 | 79 | 0.050 |
Why?
| Culture Techniques | 1 | 2000 | 21 | 0.050 |
Why?
| Electric Impedance | 1 | 2000 | 43 | 0.050 |
Why?
| Inflammasomes | 1 | 2021 | 60 | 0.050 |
Why?
| Cell Size | 1 | 2000 | 45 | 0.050 |
Why?
| Pentylenetetrazole | 1 | 2020 | 9 | 0.050 |
Why?
| Curriculum | 1 | 2023 | 429 | 0.050 |
Why?
| Calcium-Binding Proteins | 1 | 2000 | 61 | 0.050 |
Why?
| Potassium | 1 | 2000 | 60 | 0.050 |
Why?
| Interleukin-1 | 1 | 2000 | 107 | 0.050 |
Why?
| Afferent Pathways | 2 | 1989 | 8 | 0.040 |
Why?
| Trigeminal Nerve | 2 | 1989 | 9 | 0.040 |
Why?
| Nociceptors | 2 | 1989 | 17 | 0.040 |
Why?
| Kinetics | 2 | 1998 | 692 | 0.040 |
Why?
| Nerve Fibers, Myelinated | 2 | 1989 | 27 | 0.040 |
Why?
| Cell Division | 2 | 1996 | 330 | 0.040 |
Why?
| Cerebrovascular Circulation | 1 | 2020 | 137 | 0.040 |
Why?
| Tetrodotoxin | 2 | 1996 | 11 | 0.040 |
Why?
| Neurotoxins | 1 | 1998 | 15 | 0.040 |
Why?
| Cell Differentiation | 2 | 1998 | 720 | 0.040 |
Why?
| Mice, Transgenic | 1 | 2020 | 656 | 0.040 |
Why?
| Autoradiography | 2 | 1991 | 36 | 0.040 |
Why?
| Tritium | 2 | 1991 | 53 | 0.040 |
Why?
| Cytokines | 1 | 2021 | 676 | 0.040 |
Why?
| Self Efficacy | 1 | 2018 | 137 | 0.040 |
Why?
| Fellowships and Scholarships | 1 | 2018 | 117 | 0.040 |
Why?
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 1996 | 2 | 0.040 |
Why?
| 2-Amino-5-phosphonovalerate | 1 | 1996 | 7 | 0.040 |
Why?
| Histocytochemistry | 1 | 1996 | 46 | 0.030 |
Why?
| Injections | 1 | 1996 | 61 | 0.030 |
Why?
| Isoquinolines | 2 | 1993 | 25 | 0.030 |
Why?
| Sodium Channels | 1 | 1996 | 22 | 0.030 |
Why?
| Optic Nerve | 1 | 1996 | 46 | 0.030 |
Why?
| Hypothalamus | 1 | 1996 | 28 | 0.030 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 1996 | 51 | 0.030 |
Why?
| Neuroglia | 1 | 1996 | 52 | 0.030 |
Why?
| Linear Models | 1 | 1996 | 309 | 0.030 |
Why?
| Biopsy | 1 | 2018 | 692 | 0.030 |
Why?
| Calcium Channels | 3 | 1998 | 59 | 0.030 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 543 | 0.030 |
Why?
| Iontophoresis | 1 | 1993 | 15 | 0.030 |
Why?
| Receptors, Neurotransmitter | 1 | 1992 | 15 | 0.030 |
Why?
| Parasympathomimetics | 1 | 1992 | 11 | 0.030 |
Why?
| Membranes | 1 | 1992 | 19 | 0.030 |
Why?
| Muscarinic Antagonists | 1 | 1992 | 18 | 0.030 |
Why?
| Neurotransmitter Agents | 1 | 1992 | 38 | 0.030 |
Why?
| United States | 1 | 2023 | 5217 | 0.030 |
Why?
| Nicotinic Antagonists | 1 | 1992 | 46 | 0.030 |
Why?
| Interleukin-6 | 1 | 2013 | 315 | 0.030 |
Why?
| Apoptosis | 1 | 1998 | 1300 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2013 | 434 | 0.020 |
Why?
| Prostaglandin D2 | 1 | 2011 | 27 | 0.020 |
Why?
| Fetus | 1 | 2012 | 227 | 0.020 |
Why?
| Cell Count | 1 | 2011 | 181 | 0.020 |
Why?
| Impromidine | 1 | 1990 | 1 | 0.020 |
Why?
| Cimetidine | 1 | 1990 | 8 | 0.020 |
Why?
| Guanidines | 1 | 1990 | 36 | 0.020 |
Why?
| Photomicrography | 1 | 1989 | 7 | 0.020 |
Why?
| Kynurenic Acid | 1 | 1989 | 4 | 0.020 |
Why?
| Reticular Formation | 1 | 1989 | 23 | 0.020 |
Why?
| Imidazoles | 1 | 1990 | 142 | 0.020 |
Why?
| Staining and Labeling | 1 | 1989 | 106 | 0.020 |
Why?
| Amino Acids | 1 | 1991 | 369 | 0.020 |
Why?
| Calcium | 1 | 1990 | 432 | 0.020 |
Why?
| Potassium Chloride | 2 | 1998 | 18 | 0.020 |
Why?
| Cyclodextrins | 2 | 1998 | 17 | 0.020 |
Why?
| Receptors, Cell Surface | 1 | 1989 | 130 | 0.020 |
Why?
| Brain Mapping | 1 | 1989 | 250 | 0.020 |
Why?
| Vitamin E | 2 | 1998 | 107 | 0.020 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2005 | 55 | 0.020 |
Why?
| Ligands | 1 | 2005 | 230 | 0.020 |
Why?
| Adult | 1 | 2000 | 14207 | 0.010 |
Why?
| Axonal Transport | 1 | 1982 | 1 | 0.010 |
Why?
| Proline | 1 | 1982 | 31 | 0.010 |
Why?
| Insulin | 1 | 2005 | 510 | 0.010 |
Why?
| Proteins | 1 | 2005 | 376 | 0.010 |
Why?
| Leucine | 1 | 1982 | 113 | 0.010 |
Why?
| RNA, Messenger | 1 | 2005 | 1202 | 0.010 |
Why?
| Cycloheximide | 1 | 1998 | 32 | 0.010 |
Why?
| Egtazic Acid | 1 | 1998 | 16 | 0.010 |
Why?
| Aurintricarboxylic Acid | 1 | 1998 | 2 | 0.010 |
Why?
| Blood | 1 | 1998 | 30 | 0.010 |
Why?
| Membrane Lipids | 1 | 1997 | 15 | 0.010 |
Why?
| Culture Media, Serum-Free | 1 | 1997 | 20 | 0.010 |
Why?
| Ascorbic Acid | 1 | 1998 | 33 | 0.010 |
Why?
| Serotonin Receptor Agonists | 1 | 1997 | 14 | 0.010 |
Why?
| Cyclic AMP | 1 | 1998 | 106 | 0.010 |
Why?
| Amyloid beta-Peptides | 1 | 1997 | 82 | 0.010 |
Why?
| Cell Culture Techniques | 1 | 1997 | 112 | 0.010 |
Why?
| Cholesterol | 1 | 1997 | 155 | 0.010 |
Why?
| Epithelium | 1 | 1996 | 68 | 0.010 |
Why?
| Drug Resistance, Neoplasm | 1 | 1997 | 309 | 0.010 |
Why?
| Cell Membrane | 1 | 1996 | 278 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1996 | 368 | 0.010 |
Why?
| Muscarine | 1 | 1992 | 1 | 0.010 |
Why?
| GABA Antagonists | 1 | 1992 | 10 | 0.010 |
Why?
| Cell Line | 1 | 1996 | 1153 | 0.010 |
Why?
| Histamine Antagonists | 1 | 1992 | 22 | 0.010 |
Why?
| Acetic Acid | 1 | 1992 | 12 | 0.010 |
Why?
| gamma-Aminobutyric Acid | 1 | 1992 | 76 | 0.010 |
Why?
| Acetates | 1 | 1992 | 50 | 0.010 |
Why?
| Cadmium | 1 | 1990 | 27 | 0.010 |
Why?
| Neural Conduction | 1 | 1990 | 45 | 0.010 |
Why?
| Nicotine | 1 | 1992 | 207 | 0.010 |
Why?
| Receptors, Amino Acid | 1 | 1989 | 5 | 0.010 |
Why?
| Aspartic Acid | 1 | 1989 | 48 | 0.010 |
Why?
|
|
Phelan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|